Chir 12.03(1)(b)4.4. Symptoms of severe vitamin and nutritional deficiencies, and the toxicity of excess vitamin and mineral supplementation, herbals, or other nutritional supplements. Chir 12.03(1)(b)5.5. Protein, carbohydrates, and fat macronutrient needs, and symptoms of deficiencies of any of these nutrients. Chir 12.03(1)(b)7.7. Mineral and metals needs of the human body and the biochemistry of essential and non-essential nutritional supplements. Chir 12.03(1)(b)10.10. The Dietary Supplement Health and Education Act of 1994 and related regulations. Chir 12.03 NoteNote: The Dietary Supplement Health and Education Act of 1994 is also known as Public Law 103-417.
Chir 12.03(1)(b)11.11. Etiology of organ system dysfunction and internal medicine diseases and conditions. Chir 12.03(1)(b)13.13. The efficacy, safety, risks, and benefits of glandular products, chelation therapy, and therapeutic enzymes. Chir 12.03(1)(b)17.17. Contraindications, side effects, and toxic effects of botanicals, nutritional supplements, and diet products. Chir 12.03(1)(c)1.1. Provide a responsible person to monitor and verify attendance at the program. Chir 12.03(1)(c)2.2. Keep records of attendance for at least 3 years from the date of the program. Chir 12.03(1)(c)3.3. Furnish each participant with evidence of having attended the program. Chir 12.03(1)(d)(d) Any assignment or delegation of a program sponsor’s responsibilities to monitor or record attendance, provide evidence of attendance, compare course content with subject matter content required under sub. (1) (b), or provide information on instructors or other aspects of the program is specifically identified in the application under sub. (2) and approved by the board. Chir 12.03(1)(e)(e) The program sponsor has reviewed and validated the program’s content to ensure its compliance with par. (b).